[
    [
        {
            "time": "2023-10-01",
            "orginal_text": "长高新：“高新定转”转股价由86.35元/股调整为85.55元/股",
            "features": {
                "keywords": [
                    "长春高新",
                    "转股价",
                    "调整"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "长高新：“高新定转”转股价由86.35元/股调整为85.55元/股",
            "scores": {
                "News_content": "长高新：“高新定转”转股价由86.35元/股调整为85.55元/股",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-05-18",
            "orginal_text": "长春高新(000661.SZ)2020年度权益分派10派8元 股权登记日为5月18日",
            "features": {
                "keywords": [
                    "长春高新",
                    "权益分派",
                    "股权登记日"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "长春高新(000661.SZ)2020年度权益分派10派8元 股权登记日为5月18日",
            "scores": {
                "News_content": "长春高新(000661.SZ)2020年度权益分派10派8元 股权登记日为5月18日",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-01",
            "orginal_text": "华鑫证券：医药生物板块建议关注基本面稳健、估值相对合理的优质标的",
            "features": {
                "keywords": [
                    "华鑫证券",
                    "医药生物",
                    "基本面",
                    "估值"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "华鑫证券：医药生物板块建议关注基本面稳健、估值相对合理的优质标的",
            "scores": {
                "News_content": "华鑫证券：医药生物板块建议关注基本面稳健、估值相对合理的优质标的",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-01",
            "orginal_text": "2021年医药行业5月策略报告：短期波动不改长期趋势 仍重点推荐疫苗等",
            "features": {
                "keywords": [
                    "医药行业",
                    "策略报告",
                    "短期波动",
                    "长期趋势",
                    "疫苗"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "2021年医药行业5月策略报告：短期波动不改长期趋势 仍重点推荐疫苗等",
            "scores": {
                "News_content": "2021年医药行业5月策略报告：短期波动不改长期趋势 仍重点推荐疫苗等",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-01",
            "orginal_text": "医药生物行业双周报",
            "features": {
                "keywords": [
                    "医药生物",
                    "双周报"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "医药生物行业双周报",
            "scores": {
                "News_content": "医药生物行业双周报",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        }
    ]
]